---
title: "A Bumpy Ride: Q122 Spinal Cord Stimulation Market Recap"
description: "Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bumpy ride ... #neuromodulation #SpinalCordStimulation"
---

[Medical Device and Wound Care News and Analysis Blog ](https://blog.smarttrak.com)

# [A Bumpy Ride: Q122 Spinal Cord Stimulation Market Recap](https://blog.smarttrak.com/a-bumpy-ride-q122-spinal-cord-stimulation-market-recap)

 Written by [Anne Staylor](https://blog.smarttrak.com/author/anne-staylor) | 6/30/22 1:30 PM

*<https://app.smarttrak.com/analysis/qs/24c40e7553cb185aac1002bb7b1005b6>Q122 SCS Market revenues were up in the low-single digit YoY, but pandemic-related issues made it a bumpy ride*

For Q122, the spinal cord stimulation (SCS) market was up in the low-single digits YoY in both the US and WW, but pandemic-related issues made it a bumpy ride. The market was down from pre-pandemic levels for most competitors, still weakened by pandemic disruption, staffing issues and a limping recovery. 

 

Among the many topics covered in detail in our comprehensive [Q122 Spinal Cord Stimulation Market Recap](https://app.smarttrak.com/analysis/qs/24c40e7553cb185aac1002bb7b1005b6)* are:

- Complete Q122 Spinal Cord Stimulation Market Overview
- SmartTRAK's Expert Analysis and Insights
- All Market News including Revenues, Data, Charts and Shares
- Top Competitor Results & Highlights
- Important Q122 SCS News and Events

A surge in Omicron cases late in Q421 continued into January Q122 before dropping again in February, impacting revenues for some competitors more than others depending on ...

[Read the entire Q122 Spinal Cord Stimulation Market Recap, including news, data, charts, company revenues, shares and our expert analysis*](https://app.smarttrak.com/analysis/qs/24c40e7553cb185aac1002bb7b1005b6)

**The entire unedited article can only be viewed by [SmartTRAK](https://www.smarttrak.com/) subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please*[ click](https://www.smarttrak.com/contact-us) *the button below. *

[SmartTRAK](https://www.smarttrak.com/) is the leading source of competitive intelligence used by the top ten global wound care & orthopedics companies. If you would like a demo of what SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just [click here](https://landing.smarttrak.com/request-demo).

 

[View full post](https://blog.smarttrak.com/a-bumpy-ride-q122-spinal-cord-stimulation-market-recap)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Anne Staylor"
  },
  "dateModified" : "2022-07-05T18:41:40.099Z",
  "datePublished" : "2022-06-30T13:30:00Z",
  "headline" : "A Bumpy Ride: Q122 Spinal Cord Stimulation Market Recap",
  "image" : {
    "@type" : "ImageObject",
    "height" : 512,
    "url" : "https://3044256.fs1.hubspotusercontent-na1.net/hubfs/3044256/Q122SCS%20Bumpy%20Ride%20Header%20V2.png",
    "width" : 1024
  },
  "mainEntityOfPage" : "https://blog.smarttrak.com/a-bumpy-ride-q122-spinal-cord-stimulation-market-recap",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60.0,
      "url" : "https://cdn2.hubspot.net/hubfs/3044256/SmartTRAK%202.0%20Logo%20Art/SmartTRAK%20Logo%20Email250.png",
      "width" : 187.5
    },
    "name" : "SmartTRAK Life Sciences News and Analysis Blog"
  }
}
```